Inventor · disambiguated record
Jolanta Lukasiewicz
Also filed as: LUKASIEWICZ JOLANTA · LUKASIEWICZ JOLANTA KATARZYNA
7 granted patents·3 pending applications·31 citations·filing 2011–2025
81Inventor score
Files withJANSSEN PHARMACEUTICALS INC3X4 PHARMACEUTICALS AUSTRIA GMBH3ARSANIS BIOSCIENCES GMBH2LUKASIEWICZ JOLANTA1WROCLAWSKIE CT BADAN EIT & SP Z O O1
Top patents by PatentIndex Score
10 records- 0192US10940191B2MDR E. coli specific antibodyX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2018·Granted Mar 9, 2021·9 cites·27 claims
- 0290US10206992B2MDR E. coli specific antibodyARSANIS BIOSCIENCES GMBH·Filed 2016·Granted Feb 19, 2019·9 cites·23 claims
- 0389US9849169B2MDR E. coli specific antibodyARSANIS BIOSCIENCES GMBH·Filed 2014·Granted Dec 26, 2017·13 cites·5 claims
- 0482US12274742B2MDR E. coli immunogenJANSSEN PHARMACEUTICALS INC·Filed 2022·Granted Apr 15, 2025·0 cites·11 claims
- 0574US11529405B2MDR E. coli immunogenJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·0 cites·27 claims
- 0674US2025170230A1Mdr e. coli immunogenJANSSEN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0764US2023220055A1Antibodies targeting a galactan-based o-antigen of k. pneumoniaeX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2022·Application pending·0 cites
- 0850US11466074B2Antibodies targeting a galactan-based O-antigen of K. pneumoniaeX4 PHARMACEUTICALS AUSTRIA GMBH·Filed 2015·Granted Oct 11, 2022·0 cites·14 claims
- 0948US2016136285A1An isolated immunogenic bacterial antigen and its use in the prevention and treatment of infections caused by gram-negative bacteriaWROCLAWSKIE CT BADAN EIT & SP Z O O·Filed 2014·Application pending·0 cites
- 1024US9382338B2Polysaccharide and derivatives thereof, showing affinity to ficolin-3, method of preparation and useLUKASIEWICZ JOLANTA·Filed 2011·Granted Jul 5, 2016·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →